Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-labe, Controlled Study to Evaluate the Efficacy and Safety of the Combined Levonorgestrel(LNG) 100mcg and Ethinyl Estradiol(EE) 20mcg for Oral Contraception

NCT02021097 is registered in ClinicalTrials.gov with Regenex Pharmaceutical, China as lead sponsor.

NCT NCT02021097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-labe, Controlled Study to Evaluate the Efficacy and Safety of the Combined Levonorgestrel(LNG) 100mcg and Ethinyl Estradiol(EE) 20mcg for Oral Contraception
Lead sponsor
Regenex Pharmaceutical, China
Phase
Phase 3
Overall status
Unknown status
Start date
February 29, 2012
Completion date
February 29, 2016
Enrollment
1,008 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

oral contraceptive